ClinicalTrials.gg
CompletedNCT06717282Updated Mar 13, 2026Results posted

Evaluation of a Program to Enhance Ophthalmic Compliance in Children and Adolescents With Special Needs

An interventional study of visual rehabilitation for ophthalmic compliance and Using contextual, behavioral, and cognitive-based stragegies to develop training programs in Visual Rehabilitation and Visual Impairment, Autism Spectrum Disorder, Developmental Disabilities, Intellectual Disability, Behavioral Symptoms, sponsored by National Taiwan University Hospital. Completed at 1 site in Taiwan. Open to participants aged 2 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-03-13.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
2 Years to 18 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn about the effects of the structured program incorporating contextual, behavioral, and cognitive strategies to improve compliance of children and adolescents with special needs during examinations in specialized or general ophthalmic settings.

The main question it aims to answer is:

"Does this structured program increase ophthalmic examination compliance in children and adolescents with special needs?"

Participants will:

  1. Attend six individualized training sessions (one session every two weeks, each lasting one hour)
  2. Engage in activities to practice and enhance cooperation during ophthalmic examination
  3. Undergo pre- and post-program assessments to measure visal function, behavioral adaptation, and other intervention outcomes.
Read the detailed description

This study investigates the effectiveness of a contextual, behavioral, and cognitive-based intervention program designed to enhance ophthalmic compliance in children and adolescents with special needs. The program includes six individualized training sessions conducted by occupational therapists with expertise in vision rehabilitation. These sessions integrate environmental adaptation, positive reinforcement, and cognitive strategies to improve the participants' cooperation during ophthalmic examinations.

Intervention Overview:

  1. Training Sessions: Each participant will attend six one-on-one sessions over three months, with each session lasting one hour. The frequency of sessions is adjustable but generally follows a biweekly schedule.
  2. Structured Strategies: The intervention incorporates contextual strategies (e.g., simulating clinic environments), behavioral reinforcement (e.g., use of rewards), and cognitive tools (e.g., animated instructions) to facilitate learning and generalization of ophthalmic procedures.
  3. Parental Involvement: Parents will be engaged throughout the intervention to ensure continuity of training at home.

Quality assurance plan :

  1. Regular site monitoring and auditing will be conducted to maintain data quality and protocol adherence.
  2. Systematic checks will compare collected data against predefined ranges and consistency rules, ensuring reliability.
  3. Missing data will be addressed using standard imputation techniques or sensitivity analyses, ensuring robustness of the results.

Sample Size Assessment:

The study includes a planned sample size of 50 participants, which is deemed sufficient to detect significant changes in primary outcomes with appropriate statistical power.

Analysis Plan:

Primary and secondary outcomes will be assessed using appropriate statistical methods to measure changes in compliance, visual function, and behavior after the intervention.

02

Conditions studied

  • Visual Rehabilitation
  • Visual Impairment, Autism Spectrum Disorder, Developmental Disabilities, Intellectual Disability, Behavioral Symptoms

Keywords

  • Visual rehabilitation, Special need, Compliance, Ophthalmic examination
03

In context

Vision Disorders

360 studies on the registry are indexed under Vision Disorders; 84 are open to participants now.

This study's enrollment of 20 is below the median of 78 across 244 interventional studies indexed under Vision Disorders.

Browse Vision Disorders studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,615 studies on the registry; 576 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Aged between 2 and 18 years.
  2. Diagnosed with or suspected of having autism spectrum disorder, developmental delay, or intellectual disability.
  3. Experiencing difficulties cooperating with routine ophthalmologic examinations in general medical facilities due to cognitive, behavioral, or emotional challenges.

Exclusion criteria

Exclusion Criteria:

  • Children and adolescents with developmental delays or disabilities who are capable of undergoing routine vision screenings during regular ophthalmologic visits or school health check-ups.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Intervention to improve ophthalmic compliance

    Behavioral: visual rehabilitation for ophthalmic compliance · Behavioral: Using contextual, behavioral, and cognitive-based stragegies to develop training programs

Interventions

  • Behavioralvisual rehabilitation for ophthalmic compliance

    contextual, behavioral, and cognitive-based program for ophthalmic compliance

  • BehavioralUsing contextual, behavioral, and cognitive-based stragegies to develop training programs

    Key Features of the Intervention: 1. Contextual Adaptation: Participants practice ophthalmic examination procedures in a simulated clinical environment to familiarize themselves with real-world conditions. 2. Behavioral Strategies: Positive reinforcement, such as rewards (snacks, toys, or videos), is used to encourage participation and cooperation during sessions. 3. Cognitive Support: Animated materials and interactive exercises are employed to teach the concepts required for visual tests, with take-home tasks for generalization. 4. Individualized Goals: Individualized training plans and objectives are established collaboratively with caregivers based on participants' cognitive and behavioral profiles. Duration and Frequency: Six sessions, each lasting one hour, are conducted biweekly, with flexibility based on caregiver availability.

06

What researchers measure

Primary outcomes

  1. Visual Function Battery for Children With Special Needs (VFB-CSN)

    The Visual Function Battery for Children with Special Needs (VFB-CSN) is a standardized measure assessing multiple domains of visual function in children and adolescents with special needs. The VFB-CSN contains eight categories, namely visual reflex, ocular muscle balance, visual acuity, oculomotor, visual field, contrast sensitivity, colour/form vision, and visual attention. The total scores of the VFB-CSN ranges from 0 to 60. Higher scores indicate better visual function.

    Time frame: Pre-intervention and post-intervention (within 6 months)

Secondary outcomes

  1. Ophthalmic Visit Adaptation Questionnaire

    The Ophthalmic Visit Adaptation Questionnaire was developed to assess adaptive behaviors and degrees of cooperation during ophthalmic examination in both special ophthanmic clinics and general ophthalmic clinics for children/adolescents with special needs. The questionnaire consists of 18 items, and each item is rated a 5-point Likert scale raning from 1 to 5, where higher scores indicate better adaptation and cooperation. The total score is calculated by summing the 18 item scores. Therefore, total scores range from 18 to 90 (scores on a scale).

    Time frame: Baseline (pre-intervention) and post-intervention (within 6 months).

07

Results

Posted Mar 13, 2026
Limitations and caveats
This single-arm pre-post study had a small sample size and no control group, and outcome analyses were limited to participants with complete data (N = 14), which may limit generalizability.

Participant flow

Participants were recruited between December 15, 2024 and January 21, 2026 from a special needs ophthalmology clinic, including children and adolescents who attended the clinic for ophthalmic evaluation.

Participant flow — Overall Study
MilestoneExperimental: Intervention to Improve Ophthalmic Compliance
Started20
Completed20
Not completed0

Outcome measures

PrimaryVisual Function Battery for Children With Special Needs (VFB-CSN)

The Visual Function Battery for Children with Special Needs (VFB-CSN) is a standardized measure assessing multiple domains of visual function in children and adolescents with special needs. The VFB-CSN contains eight categories, namely visual reflex, ocular muscle balance, visual acuity, oculomotor, visual field, contrast sensitivity, colour/form vision, and visual attention. The total scores of the VFB-CSN ranges from 0 to 60. Higher scores indicate better visual function.

Time frame:
Pre-intervention and post-intervention (within 6 months)
Reported as:
Median · score
Visual Function Battery for Children With Special Needs (VFB-CSN)
scoreExperimental: Intervention to Improve Ophthalmic Compliance
Baseline (pre-intervention)45.00 ± 5.08
Post-intervention48.21 ± 5.47
Statistical analysis
  • Experimental: Intervention to Improve Ophthalmic Compliance · Wilcoxon signed-rank test · p = 0.008 (Two-sided p-value from Wilcoxon signed-rank test.)Baseline and post-intervention scores were compared within the same participants (N = 14).
SecondaryOphthalmic Visit Adaptation Questionnaire

The Ophthalmic Visit Adaptation Questionnaire was developed to assess adaptive behaviors and degrees of cooperation during ophthalmic examination in both special ophthanmic clinics and general ophthalmic clinics for children/adolescents with special needs. The questionnaire consists of 18 items, and each item is rated a 5-point Likert scale raning from 1 to 5, where higher scores indicate better adaptation and cooperation. The total score is calculated by summing the 18 item scores. Therefore, total scores range from 18 to 90 (scores on a scale).

Time frame:
Baseline (pre-intervention) and post-intervention (within 6 months).
Reported as:
Mean · score
Ophthalmic Visit Adaptation Questionnaire
scoreExperimental: Intervention to Improve Ophthalmic Compliance
Baseline (pre-intervention)70.80 ± 17.05
Post-intervention78.50 ± 20.17
Statistical analysis
  • Experimental: Intervention to Improve Ophthalmic Compliance · Wilcoxon Signed Rank Test · p = 0.16 (Within-participant comparison of baseline vs post-intervention total scores.)

Adverse events

Collected over From enrollment to completion of the post-intervention assessment (within 6 months).. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Experimental: Intervention to Improve Ophthalmic Compliance0/20 (0%)0/20 (0%)0/20 (0%)

Baseline characteristics

Baseline characteristics were collected for all enrolled participants (N = 20).

Age, Continuous
Age, Continuous(Years)Experimental : Intervention to Improve Ophthalmic Compliance
Mean6.82 ± 2.64
Sex: Female, Male
Sex: Female, Male(Participants)Experimental : Intervention to Improve Ophthalmic Compliance
Female8
Male12
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Experimental : Intervention to Improve Ophthalmic Compliance
08

Study locations

1 site
  • Department of Occupational Therapy, College of Medicine, National Taiwan University
    Taipei, Taiwan
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06717282
Responsible party
Sponsor
First posted
Dec 4, 2024
Start date
Dec 15, 2024
Primary completion
Jan 21, 2026
Completion
Jan 21, 2026
Results posted
Mar 13, 2026
Last update
Mar 13, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion